Crinetics Pharmaceuticals Statistics
Total Valuation
CRNX has a market cap or net worth of $4.15 billion. The enterprise value is $3.30 billion.
Market Cap | 4.15B |
Enterprise Value | 3.30B |
Important Dates
The next confirmed earnings date is Thursday, August 8, 2024, after market close.
Earnings Date | Aug 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CRNX has 78.86 million shares outstanding. The number of shares has increased by 34.10% in one year.
Shares Outstanding | 78.86M |
Shares Change (YoY) | +34.10% |
Shares Change (QoQ) | +7.45% |
Owned by Insiders (%) | 2.13% |
Owned by Institutions (%) | 105.90% |
Float | 68.47M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2,103.72 |
Forward PS | 2,473.29 |
PB Ratio | 4.75 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1,673.24 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.72, with a Debt / Equity ratio of 0.06.
Current Ratio | 17.72 |
Quick Ratio | n/a |
Debt / Equity | 0.06 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -42.50% and return on invested capital (ROIC) is -26.76%.
Return on Equity (ROE) | -42.50% |
Return on Assets (ROA) | -37.00% |
Return on Capital (ROIC) | -26.76% |
Revenue Per Employee | $6,807 |
Profits Per Employee | -$811,945 |
Employee Count | 290 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +168.54% in the last 52 weeks. The beta is 0.68, so CRNX's price volatility has been lower than the market average.
Beta (5Y) | 0.68 |
52-Week Price Change | +168.54% |
50-Day Moving Average | 47.76 |
200-Day Moving Average | 39.50 |
Relative Strength Index (RSI) | 62.26 |
Average Volume (20 Days) | 1,165,172 |
Short Selling Information
The latest short interest is 5.87 million, so 7.44% of the outstanding shares have been sold short.
Short Interest | 5.87M |
Short Previous Month | 5.86M |
Short % of Shares Out | 7.44% |
Short % of Float | 8.57% |
Short Ratio (days to cover) | 5.59 |
Income Statement
In the last 12 months, CRNX had revenue of $1.97 million and -$235.46 million in losses. Loss per share was -$3.76.
Revenue | 1.97M |
Gross Profit | 1.97M |
Operating Income | -248.16M |
Pretax Income | -235.46M |
Net Income | -235.46M |
EBITDA | -232.29M |
EBIT | -235.46M |
Loss Per Share | -$3.76 |
Balance Sheet
The company has $902.26 million in cash and $52.50 million in debt, giving a net cash position of $849.76 million or $10.78 per share.
Cash & Cash Equivalents | 902.26M |
Total Debt | 52.50M |
Net Cash | 849.76M |
Net Cash Per Share | $10.78 |
Equity (Book Value) | 874.93M |
Book Value Per Share | 11.09 |
Working Capital | 865.46M |
Cash Flow
In the last 12 months, operating cash flow was -$178.45 million and capital expenditures -$6.00 million, giving a free cash flow of -$184.45 million.
Operating Cash Flow | -178.45M |
Capital Expenditures | -6.00M |
Free Cash Flow | -184.45M |
FCF Per Share | -$2.55 |
Margins
Gross margin is 100.00%, with operating and profit margins of -12,571.38% and -11,928.27%.
Gross Margin | 100.00% |
Operating Margin | -12,571.38% |
Pretax Margin | -11,928.27% |
Profit Margin | -11,928.27% |
EBITDA Margin | -11,767.53% |
EBIT Margin | -11,928.27% |
FCF Margin | -9,343.92% |
Dividends & Yields
CRNX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -34.10% |
Shareholder Yield | -34.10% |
Earnings Yield | -5.67% |
FCF Yield | -4.44% |
Analyst Forecast
The average price target for CRNX is $65.33, which is 24.06% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $65.33 |
Price Target Difference | 24.06% |
Analyst Consensus | Strong Buy |
Analyst Count | 12 |
Revenue Growth Forecast (5Y) | 152.58% |
EPS Growth Forecast (5Y) | -54.57% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CRNX has an Altman Z-Score of 23.38 and a Piotroski F-Score of 2.
Altman Z-Score | 23.38 |
Piotroski F-Score | 2 |